| MT1JP |
|
metallothionein 1J, pseudogene
|
|
|
0.588 |
0.731 |
| MIRLET7E |
|
microRNA let-7e
|
|
|
0.592 |
0.769 |
| TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
| WG |
|
Wegener granulomatosis
|
|
|
0.595 |
0.808 |
| LOC105379528 |
|
uncharacterized LOC105379528
|
|
|
0.617 |
0.615 |
| LOC390714 |
|
immunoglobulin heavy chain variable region
|
|
|
0.617 |
0.615 |
| MIR346 |
|
microRNA 346
|
|
|
0.631 |
0.615 |
| H3P42 |
|
H3 histone pseudogene 42
|
|
|
0.641 |
0.577 |
| GCY |
|
growth control, Y chromosome influenced
|
|
|
0.631 |
0.615 |
| MT1IP |
|
metallothionein 1I, pseudogene
|
|
|
0.653 |
0.654 |
| ZNRD1ASP |
|
zinc ribbon domain containing 1 antisense, pseudogene
|
|
|
0.691 |
0.538 |
| HLA-DRB9 |
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
|
0.682 |
0.654 |
| MIR4443 |
|
microRNA 4443
|
|
|
0.729 |
0.385 |
| MIR3681HG |
|
MIR3681 host gene
|
|
|
0.736 |
0.269 |
| ATP6V1G2-DDX39B |
|
ATP6V1G2-DDX39B readthrough (NMD candidate)
|
|
|
0.769 |
0.423 |
| MIR762 |
|
microRNA 762
|
|
|
0.769 |
0.423 |
| SNHG32 |
|
small nucleolar RNA host gene 32
|
|
2.4E-02 |
0.805 |
0.308 |
| HLA-DPA2 |
|
major histocompatibility complex, class II, DP alpha 2 (pseudogene)
|
|
|
0.780 |
0.538 |
| HLA-J |
|
major histocompatibility complex, class I, J (pseudogene)
|
|
|
0.861 |
0.269 |
| AITD1 |
|
Autoimmune thyroid disease, susceptibility to, 1
|
|
|
0.861 |
0.115 |
| BHLHB9P1 |
|
basic helix-loop-helix family member b9 pseudogene 1
|
|
|
1.000 |
0.115 |
| GRD2 |
|
Graves disease, susceptibility to, 2
|
|
|
1.000 |
0.115 |
| HFM1 |
A2PYH4
|
helicase for meiosis 1
|
|
4.7E-32 |
0.659 |
0.615 |
| KCNJ18 |
B7U540
|
potassium inwardly rectifying channel subfamily J member 18
|
|
|
0.722 |
0.346 |
| MUC22 |
E2RYF6
|
mucin 22
|
|
1.4E-02 |
0.729 |
0.500 |